Griseofulvin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 125 mg, 250 mg, 500 mg
Reference Brands: Grifulvin V(US); Griséofulvine(EU)
Category: Anti-fungal
Griseofulvin inhibits fungal cell mitosis by disrupting microtubule formation, preventing fungal replication. It effectively treats dermatophyte skin, hair, and nail infections. Benefits include targeted oral therapy, good tissue penetration, and proven efficacy against dermatophytes, making it a reliable option for managing superficial fungal infections. Griseofulvin Tablets is available in Tablets and strengths such as 125 mg, 250 mg, 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Griseofulvin Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Griseofulvin Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Griseofulvin tablets are approved in the EU and US for treating dermatophyte skin infections. In the EU, generic formulations are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data, with both branded and generic versions available. Both regions require detailed dossiers for approval and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We help facilitate smooth market access for griseofulvin tablets, ensuring adherence to European and American standards for effective treatment of dermatophyte infections.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Griseofulvin is used to treat fungal infections of the skin, hair, and nails caused by dermatophytes such as tinea capitis, tinea corporis, tinea pedis, and tinea unguium. It works by disrupting fungal cell division and binding to keratin, allowing new, healthy tissue to grow and replace the infected areas.
Griseofulvin contains the antifungal compound griseofulvin, produced from the Penicillium species. It is formulated with pharmaceutical excipients that support proper absorption and therapeutic effectiveness after oral administration.
Common trade names include Grifulvin V and Gris-PEG, used in the USA and other global regions.
Grifulvin V and similar branded versions have been manufactured by companies such as Breckenridge Pharmaceutical and other licensed producers depending on the market. Various GMP-certified manufacturers also supply generic griseofulvin internationally.
The generic name is griseofulvin.
Common brand names include Grifulvin V and Gris-PEG.
Griseofulvin is manufactured in multiple GMP-certified facilities globally, including established production sites in the USA and Europe, along with several approved manufacturers providing generic griseofulvin to international markets.
Related Products
Naftifine Hydrochloride
Strength:
1 %, 2%
Form: Cream / Gel
Reference Brands: Naftin (USA), Xolafin (USA)
View Details
Sertaconazole Nitrate
Strength:
2 %
Form: Creams
Reference Brands: Ertaczo (USA), Zalain (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
